G Borretta
Overview
Explore the profile of G Borretta including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
607
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chianelli M, Busetto L, Vettor R, Annibale B, Paoletta A, Papini E, et al.
J Endocrinol Invest
. 2024 Apr;
47(6):1361-1371.
PMID: 38630213
Aim: This guideline (GL) is aimed at providing a clinical practice reference for the management of adult patients with overweight or obesity associated with metabolic complications who are resistant to...
2.
Arosio M, Sciannameo V, Contarino A, Berchialla P, Puglisi S, Pesatori A, et al.
J Endocrinol Invest
. 2024 Jan;
47(6):1457-1465.
PMID: 38214852
Objective: This study aimed to assess the long-term outcome of patients with acromegaly. Design: This is a multicenter, retrospective, observational study which extends the mean observation period of a previously...
3.
Castellano E, Attanasio R, Boriano A, Gianotti L, Borretta G
J Endocrinol Invest
. 2023 Dec;
47(6):1505-1511.
PMID: 38129742
Purpose: Serum calcium/phosphate ratio (Ca/P) has been recently proposed as an additional tool to identify primary hyperparathyroidism (PHPT), especially in patients with subclinical presentation, with a proposed cut-off of 3.3...
4.
Puglisi S, Rossini A, Tabaro I, Cannavo S, Ferrau F, Ragonese M, et al.
J Endocrinol Invest
. 2020 Aug;
44(4):865-872.
PMID: 32779106
Purpose: The impact of patient's characteristics on glucocorticoid (GC) replacement therapy in adrenal insufficiency (AI) is poorly evaluated. Aims of this study were to assess the influence of sex and...
5.
Castellano E, Attanasio R, Giagulli V, Boriano A, Terzolo M, Papini E, et al.
J Diabetes Metab Disord
. 2019 Mar;
17(2):401-402.
PMID: 30919831
[This corrects the article DOI: 10.1007/s40200-018-0358-2.].
6.
Castellano E, Attanasio R, Giagulli V, Boriano A, Terzolo M, Papini E, et al.
J Diabetes Metab Disord
. 2019 Mar;
17(2):393-399.
PMID: 30918874
Objective: To evaluate the basal/total ratio of daily insulin dose (b/T) in outpatients with diabetes type 1 (DM1) and type 2 (DM2) on basal-bolus regimen, by investigating whether there is...
7.
Saponaro F, Cetani F, Repaci A, Pagotto U, Cipriani C, Pepe J, et al.
J Endocrinol Invest
. 2018 Apr;
41(11):1339-1348.
PMID: 29616419
Purpose: Evaluation of the phenotype of primary hyperparathyroidism (PHPT), adherence to International Guidelines for parathyroidectomy (PTx), and rate of surgical cure. Method: From January 2014-January 2016, we performed a prospective,...
8.
9.
Castellano E, Tassone F, Attanasio R, Gianotti L, Pellegrino M, Borretta G
J Endocrinol Invest
. 2015 Dec;
39(3):349-54.
PMID: 26620949
Background: Mild primary hyperparathyroidism (PHPT) was recently clearly defined for the first time. Our study was thus aimed to pinpoint proportion and clinical characteristics of this kind of patients. Design...
10.
Castellano E, Pellegrino M, Attanasio R, Guarnieri V, Maffe A, Borretta G
Endocrinol Diabetes Metab Case Rep
. 2015 Apr;
2015:150019.
PMID: 25859391
Unlabelled: We report the association of primary hyperparathyroidism (PHPT) and Klinefelter's syndrome (KS) in a 22-year-old male complaining of worsening fatigue. PHPT was asymptomatic at the diagnosis, but the patient...